Børresen-Dale AL - Search Results

1

TP53 mutations and codon 72 genotype--impact on survival among ovarian cancer patients.

Wang Y, Kristensen GB, Børresen-Dale AL, Helland A. Wang Y, et al. Ann Oncol. 2007 May;18(5):964-6. doi: 10.1093/annonc/mdm134. Ann Oncol. 2007. PMID: 17488735 Free article. No abstract available.

2

TP53 mutations in early-stage ovarian carcinoma, relation to long-term survival.

Wang Y, Helland A, Holm R, Skomedal H, Abeler VM, Danielsen HE, Tropé CG, Børresen-Dale AL, Kristensen GB. Wang Y, et al. Br J Cancer. 2004 Feb 9;90(3):678-85. doi: 10.1038/sj.bjc.6601537. Br J Cancer. 2004. PMID: 14760384 Free PMC article.

3

Mutations in the TP53 gene and protein expression of p53, MDM 2 and p21/WAF-1 in primary cervical carcinomas with no or low human papillomavirus load.

Helland A, Karlsen F, Due EU, Holm R, Kristensen G, Børresen-Dale Al. Helland A, et al. Br J Cancer. 1998 Jul;78(1):69-72. doi: 10.1038/bjc.1998.444. Br J Cancer. 1998. PMID: 9662253 Free PMC article.

4

ATM mutations in Finnish breast cancer patients.

Allinen M, Launonen V, Laake K, Jansen L, Huusko P, Kääriäinen H, Børresen-Dale AL, Winqvist R. Allinen M, et al. J Med Genet. 2002 Mar;39(3):192-6. doi: 10.1136/jmg.39.3.192. J Med Genet. 2002. PMID: 11897822 Free PMC article. No abstract available.

5

Potential tumorigenic programs associated with TP53 mutation status reveal role of VEGF pathway.

Joshi H, Bhanot G, Børresen-Dale AL, Kristensen V. Joshi H, et al. Br J Cancer. 2012 Nov 6;107(10):1722-8. doi: 10.1038/bjc.2012.461. Epub 2012 Oct 18. Br J Cancer. 2012. PMID: 23079576 Free PMC article.

6

Identifying microRNAs regulating B7-H3 in breast cancer: the clinical impact of microRNA-29c.

Nygren MK, Tekle C, Ingebrigtsen VA, Mäkelä R, Krohn M, Aure MR, Nunes-Xavier CE, Perälä M, Tramm T, Alsner J, Overgaard J, Nesland JM, Borgen E, Børresen-Dale AL, Fodstad Ø, Sahlberg KK, Leivonen SK. Nygren MK, et al. Br J Cancer. 2014 Apr 15;110(8):2072-80. doi: 10.1038/bjc.2014.113. Epub 2014 Feb 27. Br J Cancer. 2014. PMID: 24577056 Free PMC article.

7

Breast and other cancers in 1445 blood relatives of 75 Nordic patients with ataxia telangiectasia.

Olsen JH, Hahnemann JM, Børresen-Dale AL, Tretli S, Kleinerman R, Sankila R, Hammarström L, Robsahm TE, Kääriäinen H, Bregård A, Brøndum-Nielsen K, Yuen J, Tucker M. Olsen JH, et al. Br J Cancer. 2005 Jul 25;93(2):260-5. doi: 10.1038/sj.bjc.6602658. Br J Cancer. 2005. PMID: 15942625 Free PMC article.

8

Excess of miRNA-378a-5p perturbs mitotic fidelity and correlates with breast cancer tumourigenesis in vivo.

Winsel S, Mäki-Jouppila J, Tambe M, Aure MR, Pruikkonen S, Salmela AL, Halonen T, Leivonen SK, Kallio L, Børresen-Dale AL, Kallio MJ. Winsel S, et al. Br J Cancer. 2014 Nov 25;111(11):2142-51. doi: 10.1038/bjc.2014.524. Epub 2014 Sep 30. Br J Cancer. 2014. PMID: 25268374 Free PMC article.

9

Glomeruloid microvascular proliferation is associated with lack of response to chemotherapy in breast cancer.

Akslen LA, Straume O, Geisler S, Sørlie T, Chi JT, Aas T, Børresen-Dale AL, Lønning PE. Akslen LA, et al. Br J Cancer. 2011 Jun 28;105(1):9-12. doi: 10.1038/bjc.2011.203. Epub 2011 Jun 14. Br J Cancer. 2011. PMID: 21673677 Free PMC article.

10

Risk for contralateral breast cancer among carriers of the CHEK2*1100delC mutation in the WECARE Study.

Mellemkjaer L, Dahl C, Olsen JH, Bertelsen L, Guldberg P, Christensen J, Børresen-Dale AL, Stovall M, Langholz B, Bernstein L, Lynch CF, Malone KE, Haile RW, Andersson M, Thomas DC, Concannon P, Capanu M, Boice JD Jr; WECARE Study Collaborative Group; Bernstein JL. Mellemkjaer L, et al. Br J Cancer. 2008 Feb 26;98(4):728-33. doi: 10.1038/sj.bjc.6604228. Epub 2008 Feb 5. Br J Cancer. 2008. PMID: 18253122 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

508 results

Search Page